Partial stereotactic ablative boost radiotherapy in bulky non-small cell lung cancer: a retrospective study

Overview of attention for article published in OncoTargets and therapy, May 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter: 3 X users

reddit: 1 Redditor

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 10 Mendeley

Summary X Reddit Dimensions citations

So far, Dimensions has found 7 publications that cite this research output.

7

The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.

Treatment-related neuroendocrine prostate cancer managed with partial stereotactic ablative radiotherapy (P-SABR) for long-term survival: a case series

Article in Translational Andrology and Urology (January 2023)

Outcomes of High-Dose Stereotactic Ablative Radiotherapy to All/Multiple Sites for Oligometastatic Renal Cell Cancer Patients

Article in Current Oncology (October 2022)

Partial stereotactic ablative boost radiotherapy in bulky non-small cell lung cancer: a dosimetric comparison between proton and photon

Article in Chinese Journal of Radiation Oncology (August 2022)